Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 446

1.

Pregnancy and Cancer: the INCIP Project.

Maggen C, Wolters VERA, Cardonick E, Fumagalli M, Halaska MJ, Lok CAR, de Haan J, Van Tornout K, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP).

Curr Oncol Rep. 2020 Feb 5;22(2):17. doi: 10.1007/s11912-020-0862-7. Review.

PMID:
32025953
2.

Atypical Lesions of the Breast and Lobular Carcinoma in Situ in Pregnancy - Surgeons' Practice.

Alipour S, Omranipour R, Amant F, Eslami B.

Eur J Breast Health. 2020 Jan 1;16(1):16-21. doi: 10.5152/ejbh.2019.5158. eCollection 2020 Jan.

3.

The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies.

Marinelli O, Annibali D, Aguzzi C, Tuyaerts S, Amant F, Morelli MB, Santoni G, Amantini C, Maggi F, Nabissi M.

Front Oncol. 2019 Oct 15;9:1073. doi: 10.3389/fonc.2019.01073. eCollection 2019. Review.

4.

Noninvasive Prenatal Testing and Detection of Occult Maternal Malignancies.

Lenaerts L, Jatsenko T, Amant F, Robert Vermeesch J.

Clin Chem. 2019 Dec;65(12):1484-1486. doi: 10.1373/clinchem.2019.306548. Epub 2019 Oct 11. No abstract available.

PMID:
31604758
5.

Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?

Lenaerts L, Tuveri S, Jatsenko T, Amant F, Vermeesch JR.

Acta Clin Belg. 2020 Feb;75(1):9-18. doi: 10.1080/17843286.2019.1671653. Epub 2019 Oct 3.

PMID:
31578135
6.

Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.

Maggen C, Dierickx D, Lugtenburg P, Laenen A, Cardonick E, Smakov R, Bellido M, Cabrera-Garcia A, Gziri MM, Halaska MJ, Ottevanger PB, Van Calsteren K, O'Laughlin A, Polushkina E, Van Dam L, Avivi I, Vandenberghe P, Woei-A-Jin FJSH, Amant F; International Network on Cancer, Infertility and Pregnancy.

Lancet Haematol. 2019 Nov;6(11):e551-e561. doi: 10.1016/S2352-3026(19)30195-4. Epub 2019 Sep 26.

PMID:
31564649
7.

Treatment of Ovarian Cancer With Intraperitoneal Platinum: Heating Up the Debate.

De Jaeghere EA, Gremonprez FB, Tummers PG, Willaert WC, Ceelen WP, Amant FC, Denys HG.

J Clin Oncol. 2019 Nov 20;37(33):3169-3170. doi: 10.1200/JCO.19.01179. Epub 2019 Sep 25. No abstract available.

PMID:
31553679
8.

Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy.

Maggen C, Lok CA, Cardonick E, van Gerwen M, Ottevanger PB, Boere IA, Koskas M, Halaska MJ, Fruscio R, Gziri MM, Witteveen PO, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP).

Acta Obstet Gynecol Scand. 2020 Jan;99(1):79-88. doi: 10.1111/aogs.13731. Epub 2019 Oct 16.

9.

Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.

Lof P, van de Vrie R, Korse CM, van Driel WJ, van Gent MDJM, Karlsen MA, Amant F, Lok CAR.

Int J Gynecol Cancer. 2019 Oct;29(8):1304-1310. doi: 10.1136/ijgc-2019-000581. Epub 2019 Sep 11.

PMID:
31515411
10.

Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.

Blommaert J, Schroyen G, Vandenbulcke M, Radwan A, Smeets A, Peeters R, Sleurs C, Neven P, Wildiers H, Amant F, Sunaert S, Deprez S.

Hum Brain Mapp. 2019 Dec 1;40(17):4994-5010. doi: 10.1002/hbm.24753. Epub 2019 Aug 21.

PMID:
31436005
11.

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.

Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok CAR, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I.

Ann Oncol. 2019 Oct 1;30(10):1601-1612. doi: 10.1093/annonc/mdz228.

PMID:
31435648
12.

Endometrial cancer during pregnancy: management strategies.

Eriksson AG, Fallaas Dahl G, Nesbakken AJ, Lund KV, Amant F.

Int J Gynecol Cancer. 2019 Sep;29(7):1221-1224. doi: 10.1136/ijgc-2019-000756. Epub 2019 Aug 20. No abstract available.

PMID:
31434687
13.

Effects of in-utero exposure to chemotherapy on fetal brain growth.

Passera S, Contarino V, Scarfone G, Scola E, Fontana C, Peccatori F, Cinnante C, Counsell S, Ossola M, Pisoni S, Pesenti N, Grossi E, Amant F, Mosca F, Triulzi F, Fumagalli M.

Int J Gynecol Cancer. 2019 Sep;29(7):1195-1202. doi: 10.1136/ijgc-2019-000416. Epub 2019 Aug 7.

PMID:
31395614
14.

Pregnant women with confirmed neoplasms should not have noninvasive prenatal testing.

Lenaerts L, Van Calsteren K, Che H, Vermeesch JR, Amant F.

Prenat Diagn. 2019 Nov;39(12):1162-1165. doi: 10.1002/pd.5544. Epub 2019 Aug 28. No abstract available.

15.

Long-term impact of prenatal exposure to chemotherapy on executive functioning: An ERP study.

Blommaert J, Zink R, Deprez S, Myatchin I, Dupont P, Vandenbroucke T, Sleurs C, Van Calsteren K, Amant F, Lagae L.

Clin Neurophysiol. 2019 Sep;130(9):1655-1664. doi: 10.1016/j.clinph.2019.06.012. Epub 2019 Jul 9.

PMID:
31330451
16.

PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression.

Kok PS, Beale P, O'Connell RL, Grant P, Bonaventura T, Scurry J, Antill Y, Goh J, Sjoquist K, DeFazio A, Mapagu C, Amant F, Friedlander M; PARAGON Investigators.

J Gynecol Oncol. 2019 Sep;30(5):e86. doi: 10.3802/jgo.2019.30.e86.

17.

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.

Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M.

Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18.

PMID:
31227223
18.

Influence of the corticospinal tract wiring pattern on sensorimotor functional connectivity and clinical correlates of upper limb function in unilateral cerebral palsy.

Simon-Martinez C, Jaspers E, Alaerts K, Ortibus E, Balsters J, Mailleux L, Blommaert J, Sleurs C, Klingels K, Amant F, Uyttebroeck A, Wenderoth N, Feys H.

Sci Rep. 2019 Jun 3;9(1):8230. doi: 10.1038/s41598-019-44728-9.

19.

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

Tuyaerts S, Van Nuffel AMT, Naert E, Van Dam PA, Vuylsteke P, De Caluwé A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H.

BMC Cancer. 2019 May 28;19(1):506. doi: 10.1186/s12885-019-5676-3.

20.

Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.

Mileshkin L, Edmondson R, O'Connell RL, Sjoquist KM, Andrews J, Jyothirmayi R, Beale P, Bonaventura T, Goh J, Hall M, Clamp A, Green J, Lord R, Amant F, Alexander L, Carty K, Paul J, Scurry J, Millan D, Nottley S, Friedlander M; PARAGON study group.

Gynecol Oncol. 2019 Jul;154(1):29-37. doi: 10.1016/j.ygyno.2019.05.007. Epub 2019 May 23.

PMID:
31130288
21.

FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.

Plante M, van Trommel N, Lheureux S, Oza AM, Wang L, Sikorska K, Ferguson SE, Han K, Amant F.

Int J Gynecol Cancer. 2019 Jun;29(5):969-975. doi: 10.1136/ijgc-2019-000398. Epub 2019 May 17.

PMID:
31101688
22.

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study.

Visser NCM, van der Putten LJM, van Egerschot A, Van de Vijver KK, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Krakstad C, Tangen IL, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Hausnerova J, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Trovik J, Amant F, Massuger LFAG, Bulten J, Pijnenborg JMA.

Hum Pathol. 2019 Jul;89:90-98. doi: 10.1016/j.humpath.2019.04.014. Epub 2019 May 3.

PMID:
31054899
23.

Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.

de Lange NM, Ezendam NPM, Kwon JS, Vandenput I, Mirchandani D, Amant F, van der Putten LJM, Pijnenborg JMA.

Curr Oncol. 2019 Apr;26(2):e226-e232. doi: 10.3747/co.26.4655. Epub 2019 Apr 1.

24.

Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium, Massuger LFAG, Bussink J, Pijnenborg JMA.

Br J Cancer. 2019 May;120(11):1037-1044. doi: 10.1038/s41416-019-0461-2. Epub 2019 Apr 23.

PMID:
31011231
25.

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.

van Baal JOAM, Van de Vijver KK, Algera MD, van der Aa MA, Sonke GS, van Driel WJ, Kenter GG, Amant FC, Lok CAR.

Gynecol Oncol. 2019 Jun;153(3):562-567. doi: 10.1016/j.ygyno.2019.03.257. Epub 2019 Apr 1.

PMID:
30948193
26.

Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.

Halaska MJ, Uzan C, Han SN, Fruscio R, Dahl Steffensen K, Van Calster B, Stankusova H, Delle Marchette M, Mephon A, Rouzier R, Witteveen PO, Vergani P, Van Calsteren K, Rob L, Amant F.

Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103. doi: 10.1136/ijgc-2018-000103. [Epub ahead of print]

PMID:
30898935
27.

Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.

Conings S, Tseke F, Van den Broeck A, Qi B, Paulus J, Amant F, Annaert P, Van Calsteren K.

Toxicol Appl Pharmacol. 2019 May 1;370:14-23. doi: 10.1016/j.taap.2019.03.004. Epub 2019 Mar 5.

PMID:
30849458
28.

Tamoxifen and pregnancy: an absolute contraindication?

Schuurman TN, Witteveen PO, van der Wall E, Passier JLM, Huitema ADR, Amant F, Lok CAR.

Breast Cancer Res Treat. 2019 May;175(1):17-25. doi: 10.1007/s10549-019-05154-7. Epub 2019 Feb 1. Review.

PMID:
30707336
29.

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer.

Tuyaerts S, Rombauts K, Everaert T, Van Nuffel AMT, Amant F.

Front Nutr. 2019 Jan 11;5:138. doi: 10.3389/fnut.2018.00138. eCollection 2018.

30.

Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article.

Maggen C, van Gerwen M, Van Calsteren K, Vandenbroucke T, Amant F.

Int J Gynecol Cancer. 2019 Jan 18. pii: ijgc-2018-000061. doi: 10.1136/ijgc-2018-000061. [Epub ahead of print]

PMID:
30659032
31.

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, Torres J, Marques M, Habyan SA, Bijian K, Amant F, Witcher M, Behbod F, McCaffrey L, Alaoui-Jamali M, Giannakopoulos NV, Brackstone M, Postovit LM, Del Rincón SV, Miller WH Jr.

Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.

32.

Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.

Lenaerts L, Vandenberghe P, Brison N, Che H, Neofytou M, Verheecke M, Leemans L, Maggen C, Dewaele B, Dehaspe L, Vanderschueren S, Dierickx D, Vandecaveye V, Amant F, Vermeesch JR.

Ann Oncol. 2019 Jan 1;30(1):85-95. doi: 10.1093/annonc/mdy476.

33.

Development of Patient-Derived Tumor Xenograft Models.

Annibali D, Leucci E, Hermans E, Amant F.

Methods Mol Biol. 2019;1862:217-225. doi: 10.1007/978-1-4939-8769-6_15.

PMID:
30315470
34.

Cancer of the corpus uteri.

Amant F, Mirza MR, Koskas M, Creutzberg CL.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50. doi: 10.1002/ijgo.12612.

PMID:
30306580
35.

Brief Report on 3-Weekly Paclitaxel Carboplatin Efficacy in Locally Advanced or Metastatic Squamous Vulvar Cancer.

Amant F, Nooij L, Annibali D, van Rompuy AS, Han S, van den Bulck H, Goffin F.

Gynecol Obstet Invest. 2018;83(6):620-626. doi: 10.1159/000487435. Epub 2018 Sep 18.

PMID:
30227411
36.

Effects of cancer treatment during pregnancy on fetal and child development.

Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F.

Lancet Child Adolesc Health. 2017 Dec;1(4):302-310. doi: 10.1016/S2352-4642(17)30091-3. Epub 2017 Sep 29. Review.

PMID:
30169185
37.

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists.

de Geus KF, Maggen C, de Haan J, Amant F.

Oncotarget. 2018 Aug 7;9(61):31795-31796. doi: 10.18632/oncotarget.25841. eCollection 2018 Aug 7. No abstract available.

38.

Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.

Tuyaerts S, Amant F.

Vaccines (Basel). 2018 Aug 25;6(3). pii: E56. doi: 10.3390/vaccines6030056. Review.

39.

Patient-Derived Xenograft Models for Endometrial Cancer Research.

Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E.

Int J Mol Sci. 2018 Aug 17;19(8). pii: E2431. doi: 10.3390/ijms19082431. Review.

40.

Modeling Endometrial Cancer: Past, Present, and Future.

Van Nyen T, Moiola CP, Colas E, Annibali D, Amant F.

Int J Mol Sci. 2018 Aug 9;19(8). pii: E2348. doi: 10.3390/ijms19082348. Review.

41.

Identification of nine new susceptibility loci for endometrial cancer.

O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, Chen C, Chen MM, Cheng THT, Clarke CL, Clendenning M, Cook LS, Couch FJ, Cox A, Crous-Bous M, Czene K, Day F, Dennis J, Depreeuw J, Doherty JA, Dörk T, Dowdy SC, Dürst M, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, Fritschi L, Fung J, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankison SE, Healey CS, Hein A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hopper JL, Hunter DJ, Jones A, Krakstad C, Kristensen VN, Lambrechts D, Marchand LL, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Meindl A, Michailidou K, Milne RL, Mints M, Montgomery GW, Nassir R, Olsson H, Orlow I, Otton G, Palles C, Perry JRB, Peto J, Pooler L, Prescott J, Proietto T, Rebbeck TR, Risch HA, Rogers PAW, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Swerdlow AJ, Tham E, Trovik J, Turman C, Tyrer JP, Vachon C, VanDen Berg D, Vanderstichele A, Wang Z, Webb PM, Wentzensen N, Werner HMJ, Winham SJ, Wolk A, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Pharoah PDP, Dunning AM, Kraft P, De Vivo I, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ.

Nat Commun. 2018 Aug 9;9(1):3166. doi: 10.1038/s41467-018-05427-7.

42.

Corrigendum to 'Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction'[YPLAC 64C (2018) 61-70].

Verheecke M, Cortès Calabuig A, Finalet Ferreiro J, Brys V, Van Bree R, Verbist G, Everaert T, Leemans L, Gziri MM, Boere I, Halaska MJ, Van Houdt J, Amant F, Van Calsteren K.

Placenta. 2018 Sep;69:117. doi: 10.1016/j.placenta.2018.07.008. Epub 2018 Jul 24. No abstract available.

PMID:
30054016
43.

Management and outcome of colorectal cancer during pregnancy: report of 41 cases.

Kocián P, de Haan J, Cardonick EH, Uzan C, Lok CAR, Fruscio R, Halaska MJ, Amant F; Writing Committee of the International Network on Cancer, Infertility and Pregnancy (INCIP) on this particular manuscript.

Acta Chir Belg. 2019 Jun;119(3):166-175. doi: 10.1080/00015458.2018.1493821. Epub 2018 Jul 16.

PMID:
30010511
44.

Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study.

Fonnes T, Trovik J, Edqvist PH, Fasmer KE, Marcickiewicz J, Tingulstad S, Staff AC, Bjørge L, Amant F, Haldorsen IS, Werner H, Akslen LA, Tangen IL, Krakstad C.

BJOG. 2018 Dec;125(13):1695-1703. doi: 10.1111/1471-0528.15403. Epub 2018 Aug 19.

45.

2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.

Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels RM, Bol A, Neveu MC, Grégoire V, Duprez T, Lhommel R, Amant F, Hermans E, Jordan BF, Machiels JP.

Oncotarget. 2018 Jun 19;9(47):28572-28585. doi: 10.18632/oncotarget.25574. eCollection 2018 Jun 19.

46.

Genetic and microscopic assessment of the human chemotherapy-exposed placenta reveals possible pathways contributive to fetal growth restriction.

Verheecke M, Cortès Calabuig A, Finalet Ferreiro J, Brys V, Van Bree R, Verbist G, Everaert T, Leemans L, Gziri MM, Boere I, Halaska MJ, Vanhoudt J, Amant F, Van Calsteren K.

Placenta. 2018 Apr;64:61-70. doi: 10.1016/j.placenta.2018.03.002. Epub 2018 Mar 9. Erratum in: Placenta. 2018 Sep;69:117.

PMID:
29626982
47.

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.

Painter JN, O'Mara TA, Morris AP, Cheng THT, Gorman M, Martin L, Hodson S, Jones A, Martin NG, Gordon S, Henders AK, Attia J, McEvoy M, Holliday EG, Scott RJ, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Rübner M, Hall P, Czene K, Dörk T, Dürst M, Hillemanns P, Runnebaum I, Lambrechts D, Amant F, Annibali D, Depreeuw J, Vanderstichele A, Goode EL, Cunningham JM, Dowdy SC, Winham SJ, Trovik J, Hoivik E, Werner HMJ, Krakstad C, Ashton K, Otton G, Proietto T, Tham E, Mints M, Ahmed S, Healey CS, Shah M, Pharoah PDP, Dunning AM, Dennis J, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Zondervan KT, Nyholt DR, MacGregor S, Montgomery GW, Tomlinson I, Easton DF, Thompson DJ, Spurdle AB.

Cancer Med. 2018 May;7(5):1978-1987. doi: 10.1002/cam4.1445. Epub 2018 Apr 2.

48.

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma.

de Haan J, van Thienen JV, Casaer M, Hannivoort RA, Van Calsteren K, van Tuyl M, van Gerwen MM, Debeer A, Amant F, Painter RC.

Case Rep Oncol. 2018 Feb 15;11(1):119-124. doi: 10.1159/000487128. eCollection 2018 Jan-Apr.

49.

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.

Temko D, Van Gool IC, Rayner E, Glaire M, Makino S, Brown M, Chegwidden L, Palles C, Depreeuw J, Beggs A, Stathopoulou C, Mason J, Baker AM, Williams M, Cerundolo V, Rei M, Taylor JC, Schuh A, Ahmed A, Amant F, Lambrechts D, Smit VT, Bosse T, Graham TA, Church DN, Tomlinson I.

J Pathol. 2018 Jul;245(3):283-296. doi: 10.1002/path.5081. Epub 2018 Apr 30.

50.

Fertility preservation healthcare circuit and networks in cancer patients worldwide: what are the issues?

Melan K, Amant F, Veronique-Baudin J, Joachim C, Janky E.

BMC Cancer. 2018 Feb 17;18(1):192. doi: 10.1186/s12885-018-4046-x. Review.

Supplemental Content

Support Center